Clinical Trial

Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation

Study acronym: TRADR
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this study is to find out whether the use of topical tranexamic acid (TXA) into the surgical wound will result in less post-operative pain, less pain killer use, and better post-operative use of the wrist in people undergoing surgery for a wrist fracture compared to not using topical TXA (placebo).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-04-22; most recent amendment 2026-04-28.
Status change: Not Yet Recruiting → Recruiting 2026-04-28
Trial Details
NCT Number NCT06384456
Lead Sponsor University Health Network, Toronto
Conditions Distal Radius Fractures
Enrollment 90 participants
Start Date 2025-08-13
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-04